Related references
Note: Only part of the references are listed.Bridging the Gap Between RCTs and RWE Through Endpoint Selection
Robert J. LoCasale et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2021)
Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan
Katsutoshi Hiramatsu et al.
DRUGS-REAL WORLD OUTCOMES (2021)
COVID-19 in the Middle East and North Africa region: an urgent call for reliable, disaggregated and openly shared data
Sarah Wehbe et al.
BMJ GLOBAL HEALTH (2021)
Use of real-world evidence for oncology clinical decision making in emerging economies
Fernando Petracci et al.
FUTURE ONCOLOGY (2021)
What local experts expect from a health technology assessment (HTA) entity in Saudi Arabia: workshop conclusions
Hussain Abdulrahman Al-Omar et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2020)
Privacy, confidentiality, security and patient safety concerns about electronic health records
W. Bani Issa et al.
INTERNATIONAL NURSING REVIEW (2020)
Real-world data in Saudi Arabia: Current situation and challenges for regulatory decision-making
Fatemah A. Alnofal et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)
The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia
Jonathan Webster et al.
CLINICAL THERAPEUTICS (2019)
Real-world data: towards achieving the achievable in cancer care
Christopher M. Booth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Generalisability of Common Oncology Clinical Trial Eligibility Criteria in the Real World
S. Karim et al.
CLINICAL ONCOLOGY (2019)
Role of real-world evidence in informing cancer care: lessons from colorectal cancer
A. Batra et al.
CURRENT ONCOLOGY (2019)
The Contribution of Cancer Surveillance Toward Real World Evidence in Oncology
Lynne Penberthy et al.
SEMINARS IN RADIATION ONCOLOGY (2019)
Augmenting the randomized controlled trial with real-world data to aid clinical decision making in metastatic renal cell carcinoma: a systematic review and meta-analysis
Michael Moran et al.
FUTURE ONCOLOGY (2019)
Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials
Narjust Duma et al.
ONCOLOGIST (2019)
Use of real-world evidence for healthcare decision-making in the Middle East: practical considerations and future directions
Kasem S. Akhras et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2019)
A 1000 Arab genome project to study the Emirati population
Mariam Al-Ali et al.
JOURNAL OF HUMAN GENETICS (2018)
The positive impacts of Real-World Data on the challenges facing the evolution of biopharma
John Wise et al.
DRUG DISCOVERY TODAY (2018)
The use of real-world data in cancer drug development
E. Skovlund et al.
EUROPEAN JOURNAL OF CANCER (2018)
Real-world Data for Clinical Evidence Generation in Oncology
Sean Khozin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
European healthcare systems readiness to shift from 'one-size fits all' to personalized medicine
Sebastian Schee Genannt Halfmann et al.
PERSONALIZED MEDICINE (2017)
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making
Marc L. Berger et al.
VALUE IN HEALTH (2017)
Real-world Data for Clinical Evidence Generation in Oncology
Sean Khozin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Personalized medicine could transform healthcare
Sunil Mathur et al.
BIOMEDICAL REPORTS (2017)
A Comparative Analysis of Survival Outcomes Between Pancreatectomy and Chemotherapy for Elderly Patients With Adenocarcinoma of the Pancreas
Schelomo Marmor et al.
CANCER (2016)
Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study
Floor A. C. Berden et al.
PLOS ONE (2016)
Cost effectiveness of a pentavalent rotavirus vaccine in Oman
Salah Thabit Al Awaidy et al.
BMC INFECTIOUS DISEASES (2014)
Personalized oncology: Recent advances and future challenges
Madhu Kalia
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)